TAFENOQUINE

TAFENOQUINE was reported 66 times

These side effects are most commonly reported by patients taking TAFENOQUINE:

# Side effect Count
0 DEPRESSION 20
1 ANXIETY 18
2 NAUSEA 15
3 POST-TRAUMATIC STRESS DISORDER 15
4 ANGER 14
5 TINNITUS 12
6 HEADACHE 11
7 DIZZINESS 10
8 MEMORY IMPAIRMENT 10
9 MENTAL DISORDER 10
10 OFF LABEL USE 10
11 PARANOIA 10
12 SUICIDE ATTEMPT 10
13 BRAIN INJURY 9
14 MOOD SWINGS 9
15 NIGHTMARE 9
16 SUICIDAL IDEATION 9
17 ABDOMINAL DISCOMFORT 8
18 AMNESIA 8
19 DEPRESSED MOOD 8
20 DIARRHOEA 8
21 DISTURBANCE IN ATTENTION 8
22 DRUG INEFFECTIVE 8
23 DRUG RESISTANCE 8
24 VOMITING 8
25 ABNORMAL BEHAVIOUR 7
26 MALAISE 7
27 AGGRESSION 6
28 ASTHENIA 6
29 CONDITION AGGRAVATED 6
30 DEAFNESS 6
31 FATIGUE 6
32 ILL-DEFINED DISORDER 6
33 INSOMNIA 6
34 IRRITABLE BOWEL SYNDROME 6
35 ABNORMAL DREAMS 5
36 BABESIOSIS 5
37 BALANCE DISORDER 5
38 FEELING ABNORMAL 5
39 GENERAL PHYSICAL HEALTH DETERIORATION 5
40 POOR QUALITY SLEEP 5
41 SLEEP DISORDER 5
42 VERTIGO 5
43 AGITATION 4
44 ALCOHOL ABUSE 4
45 BIPOLAR DISORDER 4
46 COGNITIVE DISORDER 4
47 DECREASED APPETITE 4
48 DYSPNOEA EXERTIONAL 4
49 FRUSTRATION TOLERANCE DECREASED 4
50 HALLUCINATION 4
51 MAJOR DEPRESSION 4
52 METHAEMOGLOBINAEMIA 4
53 PRODUCT ODOUR ABNORMAL 4
54 SOCIAL AVOIDANT BEHAVIOUR 4
55 TOXICITY TO VARIOUS AGENTS 4
56 TREMOR 4
57 ADJUSTMENT DISORDER 3
58 ADVERSE DRUG REACTION 3
59 AUDITORY DISORDER 3
60 COMA 3
61 COMPLETED SUICIDE 3
62 CONFUSIONAL STATE 3
63 DISEASE RECURRENCE 3
64 EMOTIONAL DISTRESS 3
65 HYPERHIDROSIS 3
66 INFECTION 3
67 LOSS OF CONSCIOUSNESS 3
68 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3
69 MALARIA 3
70 MENTAL IMPAIRMENT 3
71 MOOD ALTERED 3
72 MUSCLE SPASMS 3
73 NEUROTOXICITY 3
74 OVERDOSE 3
75 PSYCHIATRIC SYMPTOM 3
76 RASH 3
77 SCREAMING 3
78 SEIZURE 3
79 SPEECH DISORDER 3
80 STRESS 3
81 ABDOMINAL PAIN UPPER 2
82 ABULIA 2
83 AUTOIMMUNE DISORDER 2
84 BLOOD METHAEMOGLOBIN PRESENT 2
85 BRAIN OEDEMA 2
86 CARDIAC ARREST 2
87 COLD SWEAT 2
88 CRYING 2
89 CYP2D6 POLYMORPHISM 2
90 DEHYDRATION 2
91 ENCEPHALOPATHY 2
92 HANGOVER 2
93 HYPERTENSION 2
94 HYPERVIGILANCE 2
95 HYPOTHALAMO-PITUITARY DISORDER 2
96 IMPAIRED WORK ABILITY 2
97 MIDDLE INSOMNIA 2
98 MIGRAINE 2
99 NEPHROLITHIASIS 2
100 NEUROPSYCHIATRIC SYMPTOMS 2
101 NIGHT SWEATS 2
102 PALPITATIONS 2
103 PARTNER STRESS 2
104 PERFORMANCE STATUS DECREASED 2
105 PERSONALITY CHANGE 2
106 PHOTOSENSITIVITY REACTION 2
107 PHYSICAL ASSAULT 2
108 PLASMODIUM VIVAX INFECTION 2
109 POISONING 2
110 PRODUCT USE ISSUE 2
111 RESTLESSNESS 2
112 SCHIZOPHRENIA 2
113 SOMNOLENCE 2
114 THERAPEUTIC PRODUCT EFFECT INCREASED 2
115 UNEVALUABLE EVENT 2
116 VISUAL IMPAIRMENT 2
117 VITREOUS FLOATERS 2
118 ABDOMINAL PAIN 1
119 ACUTE KIDNEY INJURY 1
120 ADRENAL DISORDER 1
121 ANAEMIA 1
122 ANAL INCONTINENCE 1
123 ANOREXIA 1
124 ANTISOCIAL PERSONALITY DISORDER 1
125 APNOEA 1
126 BACK PAIN 1
127 BLINDNESS 1
128 BLOOD ALBUMIN DECREASED 1
129 BLOOD CALCIUM DECREASED 1
130 BLOOD PRESSURE INCREASED 1
131 CAT SCRATCH DISEASE 1
132 CEREBRAL HAEMORRHAGE 1
133 CEREBROVASCULAR ACCIDENT 1
134 CHEST PAIN 1
135 CHEYNE-STOKES RESPIRATION 1
136 CHROMATURIA 1
137 COMPLEX REGIONAL PAIN SYNDROME 1
138 CONCOMITANT DISEASE PROGRESSION 1
139 CONSTIPATION 1
140 CONTRAINDICATED PRODUCT ADMINISTERED 1
141 COORDINATION ABNORMAL 1
142 CYANOSIS 1
143 CYCLIC VOMITING SYNDROME 1
144 DEATH 1
145 DENGUE FEVER 1
146 DEPERSONALISATION/DEREALISATION DISORDER 1
147 DEPRESSED LEVEL OF CONSCIOUSNESS 1
148 DIABETES MELLITUS 1
149 DISABILITY 1
150 DISSOCIATIVE DISORDER 1
151 DISTURBANCE IN SOCIAL BEHAVIOUR 1
152 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1
153 DRUG INTOLERANCE 1
154 DYSGEUSIA 1
155 DYSKINESIA 1
156 DYSPHEMIA 1
157 DYSPNOEA 1
158 EMOTIONAL DISORDER 1
159 EMOTIONAL POVERTY 1
160 EXTRA DOSE ADMINISTERED 1
161 EYE HAEMORRHAGE 1
162 FALL 1
163 FEAR OF CROWDED PLACES 1
164 FEELING COLD 1
165 FEELING OF DESPAIR 1
166 FOOD POISONING 1
167 FRACTURE 1
168 GASTRIC ULCER 1
169 GASTROENTERITIS 1
170 GASTROINTESTINAL DISORDER 1
171 HAEMATOCRIT DECREASED 1
172 HAEMOGLOBIN DECREASED 1
173 HAEMOLYTIC ANAEMIA 1
174 HEAD DISCOMFORT 1
175 HEART RATE INCREASED 1
176 HOMICIDAL IDEATION 1
177 HYPERACUSIS 1
178 HYPERGLYCAEMIA 1
179 HYPOSMIA 1
180 HYPOXIA 1
181 ILLNESS 1
182 ILLUSION 1
183 IMPAIRED GASTRIC EMPTYING 1
184 IMPAIRED QUALITY OF LIFE 1
185 IMPULSIVE BEHAVIOUR 1
186 INCOHERENT 1
187 INCONTINENCE 1
188 INCREASED APPETITE 1
189 INITIAL INSOMNIA 1
190 INJURY 1
191 INTRAVASCULAR HAEMOLYSIS 1
192 INTRUSIVE THOUGHTS 1
193 IRRITABILITY 1
194 JAUNDICE 1
195 JOINT DISLOCATION 1
196 JOINT INJURY 1
197 LIP DISCOLOURATION 1
198 LIVER FUNCTION TEST ABNORMAL 1
199 MANGANESE INCREASED 1
200 MASS 1
201 MENTAL FATIGUE 1
202 METABOLIC DISORDER 1
203 MILIARIA 1
204 MULTIPLE SCLEROSIS 1
205 MUSCLE TIGHTNESS 1
206 MUSCULAR WEAKNESS 1
207 MYALGIA 1
208 NARCOLEPSY 1
209 NEGATIVE THOUGHTS 1
210 NERVOUS SYSTEM DISORDER 1
211 NEUROPSYCHIATRIC SYNDROME 1
212 NEUTROPENIA 1
213 OCULAR ICTERUS 1
214 OROPHARYNGEAL SPASM 1
215 OXYGEN SATURATION DECREASED 1
216 PAIN 1
217 PALLOR 1
218 PANCREATITIS 1
219 PANIC ATTACK 1
220 PANIC REACTION 1
221 PATHOGEN RESISTANCE 1
222 PHOTOPHOBIA 1
223 PRE-EXISTING CONDITION IMPROVED 1
224 PRODUCT ADMINISTRATION INTERRUPTED 1
225 PRODUCT DOSE OMISSION ISSUE 1
226 PRODUCT PRESCRIBING ISSUE 1
227 PRODUCT TASTE ABNORMAL 1
228 PRODUCT USE COMPLAINT 1
229 PRODUCT USE IN UNAPPROVED INDICATION 1
230 PROTEIN TOTAL DECREASED 1
231 PSYCHOTIC DISORDER 1
232 PSYCHOTIC SYMPTOM 1
233 PYREXIA 1
234 RAPID EYE MOVEMENTS SLEEP ABNORMAL 1
235 RASH GENERALISED 1
236 RED CELL DISTRIBUTION WIDTH INCREASED 1
237 RENAL FUNCTION TEST ABNORMAL 1
238 RESPIRATORY DISORDER 1
239 RHABDOMYOLYSIS 1
240 STIFF PERSON SYNDROME 1
241 STRESS AT WORK 1
242 STRUCK BY LIGHTNING 1
243 SWELLING 1
244 SYNCOPE 1
245 TACHYPHRENIA 1
246 THERAPEUTIC RESPONSE UNEXPECTED 1
247 THINKING ABNORMAL 1
248 THROMBOCYTOPENIA 1
249 THYROID DISORDER 1
250 THYROID GLAND INJURY 1
251 TREATMENT FAILURE 1
252 TREATMENT NONCOMPLIANCE 1
253 UNRESPONSIVE TO STIMULI 1
254 VERBAL ABUSE 1
255 VESTIBULAR DISORDER 1
256 VIIITH NERVE INJURY 1
257 VISION BLURRED 1
258 WEIGHT DECREASED 1
259 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1